Fred Xi, based in Fort Lauderdale, Florida, United States, is currently a Chief Scientist at Jingxin Pharmaceuticals, bringing experience from previous roles at Sancilio & Company, u.s. Pharmacopeia, Freemen Pharmaceuticals and Actavis (Now Allergan). Fred Xi holds a 1993 - 1995 University of Toronto. With a robust skill set that includes Organic Synthesis, Formulation, NDA, Team Building, Leadership and more, Fred Xi contributes valuable insights to the industry. Fred Xi has 3 emails on RocketReach.